154
Views
6
CrossRef citations to date
0
Altmetric
Diagnostics

Fractional exhaled nitric oxide measurement: Comparison between the Sunvou-CA2122 analyzer and the NIOX VERO analyzer

, MD, , PhD, , MD & , PhDORCID Icon
Pages 52-59 | Received 04 Jun 2019, Accepted 17 Aug 2019, Published online: 12 Sep 2019

References

  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2018. Available from: http://www.ginasthma.org [last accessed 11 April 2018].
  • Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995;1523:892–896. doi:10.1164/ajrccm.152.3.7663801.
  • Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001;1645:738–743. doi:10.1164/ajrccm.164.5.2012125.
  • Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004;414:471–476. doi:10.1081/JAS-120033990.
  • Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005;603:215–218. doi:10.1136/thx.2004.023374.
  • Beck-Ripp J, Griese M, Arenz S, Koring C, Pasqualoni B, Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002;196:1015–1019. doi:10.1183/09031936.02.01582001.
  • Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005;1727:831–836. doi:10.1164/rccm.200503-458OC.
  • Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;35221:2163–2173. doi:10.1056/NEJMoa043596.
  • ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;1718:912–930. doi:10.1164/rccm.200406-710ST.
  • Deykin A, Halpern O, Massaro AF, Drazen JM, Israel E. Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. Am J Respir Crit Care Med 1998;1573:769–775. doi:10.1164/ajrccm.157.3.9707114.
  • Silkoff PE, Wakita S, Chatkin J, Ansarin K, Gutierrez C, Caramori M, McClean P, Slutsky AS, Zamel N, Chapman KR. Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med 1999;1593:940–944. doi:10.1164/ajrccm.159.3.9805044.
  • Deykin A, Massaro AF, Coulston E, Drazen JM, Israel E. Exhaled nitric oxide following repeated spirometry or repeated plethysmography in healthy individuals. Am J Respir Crit Care Med 2000;1614:1237–1240. doi:10.1164/ajrccm.161.4.9904086.
  • Kissoon N, Duckworth LJ, Blake KV, Murphy SP, Lima JJ. Effect of beta2-agonist treatment and spirometry on exhaled nitric oxide in healthy children and children with asthma. Pediatr Pulmonol 2002;343:203–208. doi:10.1002/ppul.10154.
  • Zhou X, Ding FM, Lin JT, Yin KS, Chen P, He QY, Shen HH, Wan HY, Liu CT, Li J. Validity of asthma control test in Chinese patients. Chin Med J 2007;12012:1037–1041. doi:10.1097/00029330-200706020-00002.
  • Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;1131:59–65. doi:10.1016/j.jaci.2003.09.008.
  • Thomas M, Kay S, Pike J, Williams A, Rosenzweig JR, Hillyer EV, Price D. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J 2009;181:41–49. doi:10.4104/pcrj.2009.00010.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P. Standardisation of spirometry. Eur Respir J 2005;262:319–338. doi:10.1183/09031936.05.00034805.
  • Brooks CR, Brogan SB, van Dalen CJ, Lampshire PK, Crane J, Douwes J. Measurement of exhaled nitric oxide in a general population sample: a comparison of the Medisoft HypAir FE(NO) and Aerocrine NIOX analyzers. J Asthma 2011;484:324–328. doi:10.3109/02770903.2011.560322.
  • Inoue Y, Sato S. Measurement of exhaled nitric oxide in children: a comparison between NObreath(R) and NIOX VERO(R) Analyzers. Allergy Asthma Immunol 2018;105:478–489. doi:10.4168/aair.2018.10.5.478.
  • Korn S, Telke I, Kornmann O, Buhl R. Measurement of exhaled nitric oxide: comparison of different analysers. Respirology (Carlton, Vic) 2010;158:1203–1208. doi:10.1111/j.1440-1843.2010.01847.x.
  • Pisi R, Aiello M, Tzani P, Marangio E, Olivieri D, Chetta A. Measurement of fractional exhaled nitric oxide by a new portable device: comparison with the standard technique. J Asthma 2010;477:805–809. doi:10.3109/02770903.2010.485667.
  • Pizzimenti S, Bugiani M, Piccioni P, Heffler E, Carosso A, Guida G, Rolla G. Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer. Respir Med 2008;1029:1272–1275. doi:10.1016/j.rmed.2008.04.006.
  • Tanabe Y, Harada N, Ito J, Matsuno K, Takeshige T, Harada S, Takemasa M, Kotajima M, Ishimori A, Katsura Y. Difference between two exhaled nitric oxide analyzers, NIOX VERO((R)) electrochemical hand-held analyzer and NOA280i((R)) chemiluminescence stationary analyzer. J Asthma 2019;562:167–172. doi:10.1080/02770903.2018.1439953.
  • Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;1845:602–615. doi:10.1164/rccm.9120-11ST.
  • Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995;1522:800–803. doi:10.1164/ajrccm.152.2.7633745.
  • Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet (London, England) 1994;3438890:133–135. doi:10.1016/S0140-6736(94)90931-8.
  • Bisgaard H, Loland L, Oj JA. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med 1999;1604:1227–1231. doi:10.1164/ajrccm.160.4.9903004.
  • Bratton DL, Lanz MJ, Miyazawa N, White CW, Silkoff PE. Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study. Pediatr Pulmonol 1999;286:402–407. doi:10.1002/(SICI)1099-0496(199912)28:6 < 402::AID-PPUL3 > 3.0.CO;2-V.
  • Mattes J, Storm van's Gravesande K, Moeller C, Moseler M, Brandis M, Kuehr J. Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children. Pediatr Res 2002;512:190–194. doi:10.1203/00006450-200202000-00011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.